VEGFA and macular retinal edema: In this randomized clinical trial evaluating 3 different anti-VEGF agents, ranibizumab, bevacizumab and aflibercept, treatment for macular edema due to CRVO resulted in improved and sustained visual gains when patients were followed up regularly and treated promptly.